Stockscreener 앱 받기
49.06
2.68%
1.28
시간 외 거래:
49.69
0.63
+1.28%
Terns Pharmaceuticals Inc 주식(TERN)의 최신 뉴스
Terns Pharmaceuticals stock hits all-time high at 48.27 USD - Investing.com
How Vestal Point’s Big Bet On TERN-701 At Terns Pharmaceuticals (TERN) Has Changed Its Investment Story - Yahoo Finance
Aug Setups: What is the target price for Terns Pharmaceuticals Inc stockWall Street Watch & Daily Stock Momentum Reports - baoquankhu1.vn
Superstring Capital Reduces Terns Pharmaceuticals Holding in Late 2025News and Statistics - IndexBox
Terns Pharmaceuticals CEO Burroughs sells $681k in stock By Investing.com - Investing.com Canada
Terns Pharmaceuticals CEO Amy L. Burroughs Sells Shares - TradingView
Terns Pharmaceuticals (NASDAQ: TERN) CEO sells exercised shares under plan - Stock Titan
Vestal Point Capital's Major Investment in Terns Pharma | 2026News and Statistics - IndexBox
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally - The Motley Fool
Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget
Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail
Terns Pharmaceuticals (TERN) Is Up 8.6% After Pipeline Update And Index Inclusion News - simplywall.st
Terns Pharmaceuticals Financial Outlook Raises Concerns Amid Market Trends - timothysykes.com
4 Biotech Stocks to Watch for Potential Upside in 2026 - The Globe and Mail
Terns Pharmaceuticals’ Valuation Reassessed Amid Latest Developments - StocksToTrade
Terns Pharmaceuticals CEO outlines strategy to advance novel leukemia therapy - Traders Union
Terns Pharmaceuticals shares rise as investors focus on recent presentation, index-addition notice, and upcoming earnings - Quiver Quantitative
Terning The Flight to Innovation with Terns Pharma - TD Securities
TERN Should I Buy - Intellectia AI
TERN: TERN-701 shows best-in-disease efficacy and safety in CML, with pivotal trials and launch funded - TradingView
Dynamic Technology Lab Private Ltd Grows Stock Position in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
Terns Pharmaceuticals divulges new GLP-1R agonists - BioWorld MedTech
TERN: TERN-701 shows superior efficacy and safety in CML, positioning for major market impact - TradingView
DLD Asset Management LP Cuts Stake in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
Will Terns Pharmaceuticals Inc. stock benefit from automation2026 Opening Moves & Safe Entry Momentum Tips - Naître et grandir
Wall Street analysts see a 50.91% upside in Terns Pharmaceuticals (TERN): Can the stock really move this high? - MSN
What is Terns Pharmaceuticals Incs debt to equity ratioWeekly Stock Report & Breakout Confirmation Trade Signals - baoquankhu1.vn
Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing - The Globe and Mail
TERN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Portfolio Update: How does Terns Pharmaceuticals Inc score in quality rankingsMarket Rally & Low Risk Entry Point Tips - baoquankhu1.vn
A Look At Terns Pharmaceuticals (TERN) Valuation After Leerink Highlights Early TERN-701 CML Data - Yahoo Finance
Does Rising Hedge Fund Interest in Terns (TERN) Reveal a Deeper Bet on Single-Asset Biotech Risk? - simplywall.st
15 Stocks with the Biggest Hedge Fund Momentum - Insider Monkey
Analyst Optimistic on Terns (TERN) Citing Possible $4.8B Market for Upcoming Leukemia Drug - Yahoo Finance
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences - The Manila Times
CEO Change: Will LDWY benefit from geopolitical trends2025 Macro Impact & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
OrbiMed Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing - AOL.com
Nasdaq Moves: How does Terns Pharmaceuticals Inc score in quality rankingsQuarterly Portfolio Review & Consistent Return Investment Signals - baoquankhu1.vn
Commit To Buy Terns Pharmaceuticals At $30, Earn 34% Using Options - Nasdaq
Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge - AOL.com
Terns Pharmaceuticals (NASDAQ:TERN) Stock Rating Upgraded by TD Cowen - Defense World
Terns Pharmaceuticals (NASDAQ:TERN) Raised to "Strong-Buy" at TD Cowen - MarketBeat
What are Terns Pharmaceuticals Inc.’s technical support levels2025 Trading Recap & Consistent Profit Focused Trading Strategies - mfd.ru
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing - The Globe and Mail
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Bull Run: How does Terns Pharmaceuticals Inc score in quality rankings2025 Big Picture & Real-Time Buy Signal Alerts - baoquankhu1.vn
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Terns (TERN) CEO sells 14,583 shares after option exercise - Stock Titan
Can Terns Pharmaceuticals Inc. be the next market leaderJuly 2025 EndofMonth & Weekly Watchlist for Consistent Profits - mfd.ru
Terns Pharmaceuticals (NASDAQ:TERN) Upgraded at Wall Street Zen - MarketBeat
Block Trades: Can Terns Pharmaceuticals Inc be the next market leader2025 Technical Patterns & Growth Focused Entry Reports - baoquankhu1.vn
1.20%
0.06%
자본화:
|
볼륨(24시간):